Horwitz K B, Wei L L, Francis M D
J Steroid Biochem. 1986 Jan;24(1):109-17. doi: 10.1016/0022-4731(86)90039-7.
Progesterone receptors of T47Dco human breast cancer cells consist of two equimolar hormone-binding proteins of mol. wt approximately 85,000 (A protein) and 115,000 (B protein). Both proteins can be demonstrated in intact cells by in situ photoaffinity labeling; that is, in cells treated with the synthetic progestin [3H]R5020, irradiated 2 min with 300 nm u.v., solubilized directly in SDS and subjected to electrophoresis under denaturing conditions. These proteins are 6000-10,000 dalton heavier than the corresponding proteins of chick oviducts. This difference has been measured by direct comparison of photolabeled chick and human receptors on SDS-PAGE and by immunoblotting with the 9G10 antibody prepared against chick protein B. The antibody binds to a protein of mol. wt approximately 106,000 in human cells that is smaller than the hormone-bound B protein and larger than the hormone-bound A. In T47Dco cells, in situ photolabeled, untransformed receptors, as well as transformed nuclear-bound receptors, have equimolar amounts of A and B proteins. This ratio remains stable during a 1 h 37 degrees C in vitro incubation. Analysis of the in situ labeled receptors on gradient gels shows that the untransformed B protein exists as a doublet of mol. wt approximately 115,000 and 119,000 while the A protein is a singlet. After [3H]R5020 treatment, nuclear receptors change further: during the first 30 min in the nucleus the B protein shifts entirely to the heavier, mol. wt = 119,000 form. Between 30 and 60 min after nuclear binding, the A protein first becomes a doublet of 85,000 and 89,000 dalton then shifts entirely to the 4000 dalton heavier form. Later, nuclear processing leads to the simultaneous disappearance of both proteins without generation of smaller molecular weight fragments. Cleveland mapping studies show that the A and B proteins are closely related; despite the initial difference in the molecular weight of A and B, digestion with S. aureaus V8 protease yields identical fragmentation patterns for each, with sequential peptides of mol. wt approximately 49,000, 39,000, 26,000 and 14,000.(ABSTRACT TRUNCATED AT 400 WORDS)
T47Dco人乳腺癌细胞的孕酮受体由两种等摩尔的激素结合蛋白组成,分子量分别约为85,000(A蛋白)和115,000(B蛋白)。通过原位光亲和标记可在完整细胞中检测到这两种蛋白;即在经合成孕激素[3H]R5020处理的细胞中,用300nm紫外线照射2分钟,直接在SDS中溶解,并在变性条件下进行电泳。这些蛋白比鸡输卵管中的相应蛋白重6000 - 10,000道尔顿。通过在SDS - PAGE上直接比较光标记的鸡和人受体以及用针对鸡蛋白B制备的9G10抗体进行免疫印迹法测量了这种差异。该抗体与人类细胞中分子量约为106,000的一种蛋白结合,该蛋白比激素结合的B蛋白小,比激素结合的A蛋白大。在T47Dco细胞中,原位光标记未转化的受体以及转化的核结合受体中,A和B蛋白的量是等摩尔的。在37℃体外孵育1小时期间,该比例保持稳定。对梯度凝胶上原位标记的受体进行分析表明,未转化的B蛋白以分子量约为115,000和119,000的双峰形式存在,而A蛋白是单峰。用[3H]R5020处理后,核受体进一步变化:在细胞核中的最初30分钟内,B蛋白完全转变为分子量更大的、分子量 = 119,000的形式。核结合后30至60分钟之间,A蛋白首先变为85,000和89,000道尔顿的双峰,然后完全转变为重4000道尔顿的形式。后来,核加工导致两种蛋白同时消失,未产生更小分子量的片段。克利夫兰图谱研究表明,A和B蛋白密切相关;尽管A和B最初分子量不同,但用金黄色葡萄球菌V8蛋白酶消化后,每种蛋白产生相同的片段化模式,依次为分子量约为49,000、39,000、26,000和14,000(摘要截断于400字)